Literature DB >> 26823281

Acquired resistance to rechallenge injury after acute kidney injury in rats is associated with cell cycle arrest in proximal tubule cells.

Takamasa Iwakura1, Yoshihide Fujigaki2, Tomoyuki Fujikura1, Naro Ohashi1, Akihiko Kato3, Hideo Yasuda1.   

Abstract

Rats that have recovered from severe proximal tubule (PT) injury induced by uranyl acetate (UA), a toxic stimulus, developed resistance to subsequent UA treatment. We investigated cell cycle status and progression in PT cells in relation to this acquired resistance. Fourteen days after pretreatment with saline (vehicle group) or UA [acute kidney injury (AKI) group], rats were injected with UA or lead acetate (a proliferative stimulus). Cell cycle status (G0/G1/S/G2/M) was analyzed by flow cytometry. The expression of cell cycle markers, cyclin-dependent kinase inhibitors, and phenotypic markers were examined by immunohistochemistry. Cell cycle status in PT cells in the AKI group was comparable to those of the vehicle group. However, more early G1-phase cells (cyclin D1- or Ki67-) and p21+ or p27+ cells were found in the PT of the AKI group than in that of the vehicle group. UA induced G1 arrest and inhibited S phase progression with earlier dedifferentiation and less apoptosis in PT cells of the AKI group. Lead acetate induced proliferation without dedifferentiation but with delayed G0-G1 transition and inhibited S phase progression in PT cells in the AKI group. Sustained p21 and increased p27 expression in PT cells were found in the AKI group in response to UA and lead acetate. PT cells in the AKI group inhibited cell cycle progression by enhanced G1 arrest, probably via p21/p27 modulation as an injury or proliferation response, resulting in cytoresistance to rechallenge injury.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  G1 arrest; acquired resistance; p21/p27; proximal tubule; uranyl acetate

Mesh:

Substances:

Year:  2016        PMID: 26823281     DOI: 10.1152/ajprenal.00380.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Cytoresistance after acute kidney injury is limited to the recovery period of proximal tubule integrity and possibly involves Hippo-YAP signaling.

Authors:  Takamasa Iwakura; Yoshihide Fujigaki; Tomoyuki Fujikura; Takayuki Tsuji; Naro Ohashi; Akihiko Kato; Hideo Yasuda
Journal:  Physiol Rep       Date:  2017-06

Review 2.  Acute Kidney Injury as a Condition of Renal Senescence.

Authors:  Lucia Andrade; Camila E Rodrigues; Samirah A Gomes; Irene L Noronha
Journal:  Cell Transplant       Date:  2018-04-27       Impact factor: 4.064

3.  In Vivo Comparison of the Phenotypic Aspects and Molecular Mechanisms of Two Nephrotoxic Agents, Sodium Fluoride and Uranyl Nitrate.

Authors:  Alice Bontemps; Laurine Conquet; Christelle Elie; Victor Magneron; Céline Gloaguen; Dimitri Kereselidze; Karine Tack; Olivier C Barbier; Yann Guéguen
Journal:  Int J Environ Res Public Health       Date:  2019-03-29       Impact factor: 3.390

Review 4.  Tubular Cell Cycle Response upon AKI: Revising Old and New Paradigms to Identify Novel Targets for CKD Prevention.

Authors:  Letizia De Chiara; Carolina Conte; Giulia Antonelli; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

Review 5.  Review of Knowledge of Uranium-Induced Kidney Toxicity for the Development of an Adverse Outcome Pathway to Renal Impairment.

Authors:  Yann Guéguen; Marie Frerejacques
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 6.  The Hippo pathway and its correlation with acute kidney injury.

Authors:  Chi Zhang; Chuan-Lei Li; Ke-Xin Xu; Zhi-Huang Zheng; Guo-Zhe Cheng; Hui-Juan Wu; Jun Liu
Journal:  Zool Res       Date:  2022-09-18

7.  Trib1 Contributes to Recovery From Ischemia/Reperfusion-Induced Acute Kidney Injury by Regulating the Polarization of Renal Macrophages.

Authors:  Xiangcheng Xie; Xiu Yang; Junxia Wu; Jilin Ma; Wei Wei; Xiao Fei; Ming Wang
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.